Also trades as: AFP.AX (ASX) · $vol 0M
AFT.NZ NZE
AFT Pharmaceuticals Limited
1W: -0.5%
1M: -0.2%
3M: +17.8%
YTD: +17.5%
1Y: +68.7%
3Y: +23.1%
5Y: -1.6%
NZ$4.30 ($2.41)
-0.07 (-1.60%)
Weekly Expected Move ±2.4%
NZ$4
NZ$4
NZ$4
NZ$4
NZ$5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$12M
-189.2% ▼
Capital Expenditures
$116K
+98.3% ▲
5Y CAGR: -54.9%
Free Cash Flow
-$12M
-290.6% ▼
Dividends Paid
$2M
-12.5% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$870K
+6.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $20M | $11M | $16M | $0 | $15M |
| Depreciation & Amort. | $1M | $2M | $2M | $0 | $4M |
| Stock-Based Comp. | $13K | $0 | $139K | $0 | $0 |
| Change in Working Capital | -$7M | -$7M | $2M | -$4M | -$34M |
| Other Non-Cash Items | $8M | $4M | $6M | $17M | $4M |
| Operating Cash Flow | $12M | $9M | $26M | $13M | -$12M |
| — Investing Activities — | |||||
| Capital Expenditures | -$6M | -$9M | -$116K | -$281K | -$10M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$5M | -$9M | -$9M | -$7M | $0 |
| Investing Cash Flow | -$6M | -$9M | -$10M | -$7M | -$10M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1M | -$4M | -$5M | -$2M | $14M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | -$1M | -$2M | -$2M |
| Other Financing | $791K | -$3M | -$4M | -$4M | -$1M |
| Financing Cash Flow | -$4M | -$7M | -$11M | -$7M | $11M |
| Net Change in Cash | $5M | -$5M | $9M | -$930K | -$870K |
| Cash End of Period | $8M | $3M | $12M | $11M | $10M |
| Free Cash Flow | $7M | -$173K | $16M | $6M | -$12M |